A Clinical Study on Predicting the Depth of Double-Lumen Tube Insertion Based on Height and Sitting Height

August 5, 2025 updated by: Qin Zhang, Tongji Hospital

A Clinical Study Comparing the Prediction of Double-Lumen Tube Insertion Depth Based on Height and Sitting Height

This study employed a combined observational derivation and randomized validation approach to establish and evaluate predictive models for the depth of DLT insertion (Figure 1). Initially, a total of 98 patients scheduled for thoracic surgery involving one-lung ventilation were screened for participation. Sixteen patients were subsequently excluded because DLT was not performed, resulting in 82 participants included in the final analysis. This phase led to the development of three predictive formulas for DLT insertion depth: based on standing height (Depth = 1.083 + 0.166 × standing height), sitting height (Depth = 0.32 × SH), and an integrated model combining body height and sternum-carina distance (Ds-c: Depth = 1.543 + 0.155 × standing height + 0.202 × Ds-c).

The subsequent phase involved a triple-arm randomized controlled trial (RCT) with 336 patients to compare these predictive models. Sample size was calculated to detect a 0.3 cm error reduction with 90% power (α=0.05), requiring 102/group; 112/group were enrolled accounting for 10% attrition. The random allocation ratio was 1:1:1, ensuring equal distribution among three groups: standing height (height-based formula), sitting height (sitting height-based formula), and CT (CT-guided formula). Prespecified primary endpoints were: (1) Absolute error (continuous; mean difference in cm), (2) Clinical accuracy (binary; proportion with optimal positioning). Secondary outcomes included tube mispositioning rates.

Study Overview

Detailed Description

CT Measurement Methodology Thoracic CT scans were performed according to the hospital's standard diagnostic protocol and analyzed using OsiriX imaging software. Various anatomical measurements obtained from CT scans were used to predict intubation depth, including the distances from the vocal cords to the carina (Dv-c), from the cricoid to the carina (Dc-c), and from the thoracic inlet to the carina (Ds-c). Although the Dv-c measurement demonstrated the highest predictive accuracy at 90%, its clinical applicability was limited in our control group for two key reasons23. First, the standard lung CT protocol did not include imaging of the vocal cords, leading to insufficient data for this measurement in most patients. Second, marking the catheter at the glottis level prior to intubation was essential for observational purposes but did not interfere with the anesthesia induction process. Consequently, Ds-c was ultimately selected as the primary measurement for this study due to its superior predictive accuracy.

DLT Positioning Criteria The optimal positioning of the DLT was defined as having the bronchial cuff located in the main bronchus, with its edge positioned within 0.5 cm below the carina or at the carina level to ensure unobstruction of the opposite main bronchus. Additional criteria specified that the catheter tip should not obstruct the lobar bronchus opening, and the side hole should be situated above the carina, directly facing the main bronchus opening on the contralateral side. Surgeons confirmed satisfactory lung collapse on the operative side. Fiberoptic bronchoscopy was utilized to assess the optimal placement of the DLT, with evaluations conducted in the supine position after induction and again in the lateral position prior to the procedure. In the observational cohort, intubation was performed first, followed by verification. In the validation cohort, an independent physician calculated the insertion depth based on the predictive formulas. The anesthesiologist, unaware of group assignments, inserted the DLT according to the calculated depth, which was subsequently assessed by another independent physician using fiberoptic bronchoscopy. The DLT position was recorded as accurate if it fell within the optimal range; otherwise, it was deemed inaccurate.

Establishment of Prediction Formulas In the derivation cohort, standing height, sitting height, and Ds-c were documented for all participants prior to surgery. Following the induction of general anesthesia, patients were positioned for surgery, and one-lung ventilation commenced. The investigator recorded the catheter type and depth after the surgeon approved lung collapse on the operated side, and the anesthesiologist confirmed the catheter's optimal position using fiberoptic bronchoscopy. Regression analysis was employed to derive the prediction formulas based on height and CT measurements Validation Phase Protocol The RCT phase randomized 336 eligible patients equally into three groups using a computer-generated allocation: standing height (height-based formula), sitting height (sitting height-based formula), and CT (CT-guided formula). Preoperative standing height/sitting height measurements, as well as CT analysis, were completed before randomization. Anesthesiologists accessed group assignments through sealed opaque envelopes after patient positioning. All intubations were performed by senior airway specialists using manufacturer-recommended DLT sizes, with initial placement at the formula-predicted depth. After anesthesia induction, patients were positioned laterally to ensure alignment of the head and neck with the spine. An additional observer, blinded to group assignments, used fiberoptic bronchoscopy through the side hole of the bronchial tube to assess the location of the bronchial cuff. The target was to achieve the 'predicted depth.' Data were considered accurate if the depth fell within the 'optimal position' range. If the 'predicted depth' was not attained but a safe critical point was reached, adjustments to the catheter position were halted, and the data were recorded as inaccurate. Depths were classified as shallow if below the 'optimal position' and deep if exceeding it. All intubating anesthesiologists were board-certified specialists with >200 documented DLT placements and current certification in advanced airway management.

Blinding Procedures Participants, outcome assessors, data analysts, and data collectors were fully blinded to group allocation, while intubating clinicians were masked to group assignment and prediction formulas. Independent outcomes assessment was ensured through a three-level blinding system: (1) intubating clinicians received only numerical insertion depths from an independent coordinator without access to prediction methods or group information; (2) fiberoptic bronchoscopy verification used video recordings anonymized by removing group and patient identifiers; and (3) data collection was performed by research nurses unaware of allocations while data analysts processed datasets stripped of randomization codes. Identical interventions were maintained across all groups through standardized DLT models, uniform intubation equipment, and consistent procedural protocols.

Harm Monitoring Procedure-related adverse events specifically attributable to DLT placement (including mucosal injury and hypoxemia defined as SpO₂ <90% persisting >30 seconds) were assessed during standardized bronchoscopic verification. No study-related complications occurred.

Statistical Analysis No interim analyses were planned or performed given low procedural risk and fixed enrollment target. Stopping rules would trigger if >10% participants experienced protocol-defined serious adverse events (e.g., bronchial rupture). All statistical analyses were conducted using R (version 4.1.1; R Foundation for Statistical Computing, Vienna, Austria). Statistical significance was defined as a two-sided P value <0.05.

Descriptive statistics were used to summarize baseline characteristics. Continuous variables were assessed for normality using skewness, kurtosis, and visual inspection of histograms. Normally distributed variables were reported as means with standard errors (SE) and compared using independent samples t-tests. Non-normally distributed data were summarized as medians with interquartile ranges (IQR) and compared using the Mann-Whitney U test. Categorical variables were presented as counts and percentages and analyzed using Pearson's χ² test.

To evaluate the association between anthropometric measurements (standing height, sitting height, sternum-carina distance) and actual double-lumen tube (DLT) depth, Spearman correlation coefficients were calculated.

The primary analysis compared the predictive accuracy of three models (standing height-based, sitting height-based, and CT-guided) using a one-way analysis of variance (ANOVA). When ANOVA indicated statistical significance and homogeneity of variances (tested using Levene's test), Tukey's honestly significant difference (HSD) post hoc test was applied to identify pairwise differences between groups.

Prediction error (absolute difference between predicted and actual DLT depth) was treated as a continuous outcome and analyzed as described above. Clinical accuracy (defined as correct initial DLT positioning without repositioning) was analyzed as a binary outcome. Between-group comparisons were made using χ² tests, and subgroup analyses were conducted stratified by sex and torso proportions (sitting height <85 cm vs. ≥85 cm).

Missing data were minimal and handled using complete-case analysis. No imputation was performed. All analyses were conducted according to the intention-to-treat principle.

Study Type

Interventional

Enrollment (Actual)

418

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hubei
      • Wuhan, Hubei, China, 430030
        • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Study Population

Patients undergoing general anesthesia with DLT tracheal intubation.

Description

Inclusion Criteria:

  1. Voluntary participation in research;
  2. Age ≥18 years and ≤80 years;
  3. Patients receiving general anesthesia and DLT tracheal intubation.

Exclusion Criteria:

  1. Patients with scoliosis or deformity;
  2. Patients who are unable to stand upright or sit;
  3. Patients with maxillary malformations or misaligned incisors;
  4. The researchers judged that it was not suitable to participate in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: Standing-based
The model equation for predicting double-lumen tube insertion depth using standing height -based: Depth = 1.083 + 0.166×BH (cm)
The model equation for predicting double-lumen tube insertion depth using standing hight -based: Depth = 1.083 + 0.166×standing hight (cm)
Experimental: sitting hight-based
The model equation for predicting double-lumen tube insertion depth using sitting height (depth = 0.32 × sitting height)
The model equation for predicting double-lumen tube insertion depth using sitting height ( depth = 0.32 × sitting height)
Experimental: CT-based
The model equation for predicting double-lumen tube insertion depth using CT (depth = 1.543 + 0.155*standing height,cm + 0.202*Ds-c,cm).
The model equation for predicting double-lumen tube insertion depth using CT depth = 1.543 + 0.155*standing hight,cm + 0.202*Ds-c,cm

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depth of Double-Lumen Tube Insertion
Time Frame: 1 day
The distance from the incisor to the protuberance was measured and recorded by fiberoptic bronchoscopy
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: QIN Zhang, phd, Tongji Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 25, 2024

Primary Completion (Actual)

February 26, 2025

Study Completion (Actual)

February 26, 2025

Study Registration Dates

First Submitted

November 25, 2024

First Submitted That Met QC Criteria

November 26, 2024

First Posted (Actual)

November 29, 2024

Study Record Updates

Last Update Posted (Actual)

August 11, 2025

Last Update Submitted That Met QC Criteria

August 5, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • TJ-IRB202411040

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Airway Management

Clinical Trials on standing hight-based

Subscribe